HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A decision analysis of streptokinase plus heparin as compared with heparin alone for deep-vein thrombosis.

AbstractBACKGROUND:
It is uncertain whether patients with proximal deep-vein thrombosis should be treated with streptokinase followed by intravenous heparin or with intravenous heparin alone. Published reports indicate that streptokinase plus heparin increases the risk of bleeding, including central nervous system bleeding and death, but decreases the risk of postphlebitic syndrome. Previous recommendations regarding these treatments have not considered patients' preferences or the values they attach to the possible outcomes of therapy.
METHODS:
We used decision analysis to combine published estimates of the probabilities of various adverse outcomes of treatment (bleeding, pulmonary embolism, postphlebitic syndrome, and death) with the values patients placed on these outcomes. We questioned 36 patients about the values they attached to each outcome. Sixteen patients had had deep-vein thrombosis, and 20 had not.
RESULTS:
By the values they attached to the outcomes, all 36 patients indicated that they were unwilling to accept an increased risk of death to avoid postphlebitic syndrome. According to the decision analysis, heparin alone was the better treatment for all 36 patients. As compared with streptokinase plus heparin, heparin alone provided 29 days of additional life expectancy over the predicted life expectancy of 20 years. Although the difference between the two treatments was small, heparin alone remained the better treatment in sensitivity analyses that examined the reasonable ranges of probabilities of the clinical outcomes.
CONCLUSIONS:
The values patients placed on the outcomes of treatment for deep-vein thrombosis support the use of heparin alone over the combined use of streptokinase and heparin.
AuthorsJ J O'Meara 3rd, R A McNutt, A T Evans, S W Moore, S M Downs
JournalThe New England journal of medicine (N Engl J Med) Vol. 330 Issue 26 Pg. 1864-9 (Jun 30 1994) ISSN: 0028-4793 [Print] United States
PMID8196729 (Publication Type: Journal Article, Meta-Analysis)
Chemical References
  • Heparin
  • Streptokinase
Topics
  • Cerebral Hemorrhage (chemically induced)
  • Decision Support Techniques
  • Heparin (administration & dosage, adverse effects, therapeutic use)
  • Humans
  • Middle Aged
  • Patient Participation (statistics & numerical data)
  • Postphlebitic Syndrome (chemically induced)
  • Probability
  • Pulmonary Embolism (chemically induced)
  • Randomized Controlled Trials as Topic
  • Risk
  • Sensitivity and Specificity
  • Streptokinase (administration & dosage, adverse effects, therapeutic use)
  • Thrombolytic Therapy (adverse effects)
  • Thrombophlebitis (drug therapy)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: